Dr. Huzaifa Yasir Khan earned his B.Sc. (Hons.) and M.Sc. degrees in Chemistry from Aligarh Muslim University (AMU), India, supported by the prestigious DST-INSPIRE Scholarship. He completed his Ph.D. in 2021 under Prof. Farukh Arjmand on the design of metal-based antitumor drug candidates, funded by the DST-INSPIRE Fellowship (JRF/SRF).

He later worked as an ICMR Research Associate at the Interdisciplinary Biotechnology Unit, AMU, where he investigated the inhibitory effects of novel metal complexes on amyloid protein aggregation—a hallmark of neurodegenerative disorders like Alzheimer’s. His research focuses on targeted drug delivery using metal–nanoparticle/peptide conjugates to overcome the limitations of conventional therapies.

Dr. Khan has presented his work at premier institutes including IIT Madras, BHU, and IISER Pune, and was awarded the Young Scientist Award for Best Oral Presentation by the Indian Council of Chemists. He completed CSIR’s skill development program on DFT at NCL Pune and serves as a peer reviewer for the Journal of Molecular Structure (Elsevier, IF 4.7). He has published several research articles in the Journal of international repute. He is also the co-author of a Springer Nature book, Advances and Prospectus of 3d Metal-Based Drug Candidates.

In 2024, he delivered an oral presentation at the I International Symposium of the Spanish METALBIO Network, titled: “Functionalized Graphene Oxide Loaded Ionic Tolfenamate Complexes as Rationally Designed Vehicle for Cancer-Targeted Drug Delivery.”